A Randomized, Crossover Study To Evaluate The Efficacy Of Inhaled Iloprost On Dynamic Hyperinflation And Exercise Tolerance In Patients With Chronic Obstructive Pulmonary Disease Irrespective Of Pulmonary Hypertension.

Trial Profile

A Randomized, Crossover Study To Evaluate The Efficacy Of Inhaled Iloprost On Dynamic Hyperinflation And Exercise Tolerance In Patients With Chronic Obstructive Pulmonary Disease Irrespective Of Pulmonary Hypertension.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 24 May 2017

At a glance

  • Drugs Iloprost (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 May 2017 Results of influence of inhaled iloprost on subset of patients from this ongoing study presented at the 113th International Conference of the American Thoracic Society
    • 24 May 2017 Results (n=12) of secondary analysis assessing the impact of exercise on c-myomiR expression, presented at the 113th International Conference of the American Thoracic Society
    • 18 Aug 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top